Fig. 3From: A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's diseaseContinuous glucose monitor (CGM) results over 7 inpatient days for representative participants on a standard diet (top 2 plots, average/daily) and on a ketogenic diet (bottom 2 plots, average/daily). The top single line plot for each representative participant indicates mean glucose values, and the bottom multiple line plot shows each day’s valuesBack to article page